Robert M Lorence Selected Research

Robert M Lorence Research Topics

11	Neoplasms (Cancer) 12/2023 - 05/2002
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 05/2012
4	Adenocarcinoma of Lung 01/2023 - 05/2012
3	Adenocarcinoma 01/2023 - 05/2012
2	Carcinoma (Carcinomatosis) 12/2023 - 04/2006
2	Disease Progression 01/2022 - 05/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Heart Failure 11/2015
1	Diarrhea 02/2013
1	Deglutition Disorders (Dysphagia) 02/2013
1	Cough 02/2013
1	Dyspnea (Shortness of Breath) 02/2013
1	Pain (Aches) 02/2013
1	Fatigue 02/2013
1	Acne Vulgaris 05/2012
1	Exanthema (Rash) 05/2012
1	Pleural Effusion (Pleural Effusions) 05/2012

9	AfatinibIBA 12/2023 - 05/2012
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 05/2012
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2013 - 05/2012
2	Gefitinib (Iressa)FDA Link 02/2013 - 05/2012
2	Tyrosine Kinase InhibitorsIBA 05/2012 - 05/2012
2	InterferonsIBA 03/2007 - 12/2003
2	Antiviral Agents (Antivirals)IBA 03/2007 - 12/2003
1	nintedanibIBA 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	PlatinumIBA 01/2023
1	pembrolizumabIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2018
1	human ERBB2 proteinIBA 11/2015

5	Drug Therapy (Chemotherapy) 01/2023 - 05/2012
5	Therapeutics 05/2021 - 05/2002
1	Radiotherapy 04/2006
1	Intravenous Administration 05/2002